HOME
>
臨床医学：内科
>
腎臓
> 極論で語る腎臓内科

極論で語る腎臓内科

出版社：	丸善出版
著者：	今井直彦(著) 香坂俊(監修)
発行日：	2015-06-20
分野：	臨床医学：内科 > 腎臓
ISBN：	9784621088869
シリーズ：	極論で語るシリーズ
電子書籍版：	2016-06-20 （電子書籍版）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

3,740 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

3,740 円(税込)

購入する

商品紹介

本書では、著者が米国で培った臨床経験をもとに、臨床の現場で遭遇する「疑問」を病態生理から解き明かし、腎臓内科の『極意』をお教えします。腎臓病の領域は、循環器の領域と異なり、大規模な臨床試験は決して多くなく、決して“派手”ではありませんが、病態生理が臨床に直結していることも少なくありません。本書では、その辺りを、実践の診療にどう結びつけるかをはっきりさせ、端的に真理を記すことでわかりやすくしています。腎臓内科医をめざす研修医・腎臓病に興味のある医学生にとって、臨床の正攻法のアプローチを学べます。

目次

極論で語る腎臓内科

―目次―

腎臓内科、まずはここから始めよう
　1章　急性腎障害［AKI］

腎臓は体内の水分のバランスを司る
　2章　脱水と浮腫［dehydration and edema］
　3章　輸液について［fluid hydration］

酸に傾こうとする血液をアルカリに
　4章　酸塩基平衡の基礎［overview of acid-base balance］
　5章　血液ガスの読み方
　　　　［interpretation of arteriol blood gas］
　6章　代謝性アルカローシス［metabolic alkalosis］
　7章　代謝性アシドーシス［metabolic acidosis］

身近な検査項目を深く捉える
　8章　低ナトリウム血症と高ナトリウム血症
　　　　　［hypo and hypernatremia］
　9章　カリウム［potassium］

最後に慢性期の腎臓管理を押える
　10章　慢性腎臓病［CKD］
　11章　腎移植［kidney transplantation］

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

腎臓内科, まずはここから始めよう

P.18 掲載の参考文献

1) Himmelfarb, J. & Ikizler, T. A. Acute Kidney Injury : Changing Lexicography, Definitions, and Epidemiology. Kidney Int. 71, 971-976 (2007).

2) Bellomo, R. et al. Acute Renal Failure-Definition, Outcome Measures, Animal Models, Fluid Therapy and Information Technology Needs : The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204-212 (2004).

3) KDIGO Clinical Practice Guideline for Acute Kidney Injury. 1-141 (2012).

4) Dennen, P., Douglas, I. S. & Anderson, R. Acute Kidney Injury in the Intensive Care Unit : An Update and Primer for the Intensivist. Crit. Care Med. 38, 261-275 (2010).

5) Coca, S. G., Peixoto, A. J., Garg, A. X., Krumholz, H. M. & Parikh, C. R. The Prognostic Importance of a Small Acute Decrement in Kidney Function in Hospitalized Patients : A Systematic Review and Meta-Analysis. Am. J. Kidney Dis. 50, 712-720 (2007).

6) Liangos, O. et al. Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients : A National Survey. Clin. J. Am. Soc. Nephrol. 1, 43-51 (2006).

7) Anderson, S. et al. Acute Kidney Injury in Older Adults. J. Am. Soc. Nephrol. 22, 28-38 (2011).

8) Palevsky, P. M. Chronic-on-Acute Kidney Injury. Kidney Int. 81, 430-431 (2012).

9) Lo, L. J. et al. Dialysis-Requiring Acute Renal Failure Increases the Risk of Progressive Chronic Kidney Disease. Kidney Int. 76, 893-899 (2009).

10) Cerda, J. et al. Epidemiology of Acute Kidney Injury. Clin. J. Am. Soc. Nephrol. 3, 881-886 (2008).

11) Pannu, N. Bidirectional Relationships Between Acute Kidney Injury and Chronic Kidney Disease. Curr. Opin. Nephrol. Hypertens. 22, 351-356 (2013).

12) Abuelo, J. G. Normotensive Ischemic Acute Renal Failure. N. Engl. J. Med. 357, 797-805 (2007).

13) Myers, B. D. & Moran, S. M. Hemodynamically Mediated Acute Renal Failure. N. Engl. J. Med. 314, 97-105 (1986).

14) Jo, S. K., Rosner, M. H., & Okusa, M. D. Pharmacologic Treatment of Acute Kidney Injury : Why Drugs Haven't Worked and What Is on the Horizon. Clin. J. Am. Soc. Nephrol. 2(2), 356-365 (2007). doi : 10.2215/CJN.03280906.

15) Hilton, R. Acute Renal Failure. BMJ 333, 786-790 (2006).

16) Himmelfarb, J., et al. Evaluation and Initial Management of Acute Kidney Injury. Clin. J. Am. Soc. Nephrol. 3(4), 962-967 (2008). doi : 10.2215/CJN.04971107.

17) Lassnigg, A. et al. Lack of Renoprotective Effects of Dopamine and Furosemide During Cardiac Surgery. J. Am. Soc. Nephrol. 11, 97-104 (2000).

18) Cantarovich, F. et al. High-Dose Furosemide for Established ARF : A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Am. J. Kidney Dis. 44, 402-409 (2004).

19) Ho, K. M. Meta-Analysis of Frusemide to Prevent or Treat Acute Renal Failure. BMJ 333, 420-426 (2006).

20) Mehta, R. L., Pascual, M. T., Soroko, S. & Chertow, G. M. PICARD Study Group. Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure. JAMA 288, 2547-2553 (2002).

21) Singri, N., Ahya, S. N. & Levin, M. L. Acute Renal Failure. JAMA 289, 747-751 (2003).

22) Licurse, A. et al. Renal Ultrasonography in the Evaluation of Acute Kidney Injury : Developing a Risk Stratification Framework. Arch. Intern. Med. 170, 1900-1907 (2010).

腎臓は体内の水分のバランスを司る

P.43 掲載の参考文献

1) McGee, S., Abernethy, W. B. III & Simel, D. L. Is This Patient Hypovolemic. JAMA 281(11), 1022-1029 (1999). doi : 10.1001/jama.281.11.1022.

2) Marik, P. E., Baram, M. & Vahid, B. Does Central Venous Pressure Predict Fluid Responsiveness? Chest. 134(1), 172 (2008). doi : 10.1378/chest.07-2331.

3) Marik, P. E., Monnet, X. & Teboul, J.-L. Hemodynamic Parameters to Guide Fluid Therapy. Ann. Intensive Care. 1 (1), 1 (2011). doi : 10.1186/2110-5820-1-1.

4) Schrier, R. W. ed. Manual of Nephrology. Lippincott Williams & Wilkins (2008).

5) Rudy, D. W., Voelker, J. R., Greene, P. K., Esparza, F. A. & Brater, D. C. Loop Diuretics for Chronic Renal Insufficiency : A Continuous Infusion is More Efficacious Than Bolus Therapy. Ann. Intern. Med. 115(5), 360-366 (1991).

6) Agarwal, R. & Sinha, A. D. Thiazide Diuretics in Advanced Chronic Kidney Disease. J. Am. Soc. Hypertens. 6, 299-308 (2012).

P.62 掲載の参考文献

1) Yunos, N. M., Bellomo, R., Hegarty, C., Story, D., Ho, L. & Bailey, M. Association Between a Chloride-liberal vs. Chloride-restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill Adults. JAMA 308(15), 1566-1572 (2012). doi : 10.1001/jama.2012.13356.

2) Yunos, N. M., Bellomo, R., Story, D. & Kellum, J. Bench-to-bedside Review : Chloride in Critical Illness. Crit. Care 14(4), 226 (2010). doi : 10.1186/cc9052.

3) Perner, A., et al. Hydroxyethyl Starch 130/0.42 Versus Ringer's Acetate in Severe Sepsis. N. Engl. J. Med. 367(2), 124-134 (2012). doi : 10.1056/NEJMoa1204242.

4) Finfer, S., et al. A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. N. Engl. J. Med. 350(22), 2247-2256 (2004). doi : 10.1056/NEJMoa040232.

5) Myburgh, J. A., et al. Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care. N. Engl. J. Med. 367(20), 1901-1911 (2012). doi : 10.1056/NEJMoa1209759.

6) Rivers, E., et al. Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock. N. Engl. J. Med. 345(19), 1368-1377 (2001). doi : 10.1056/NEJMoa010307.

7) Ferrer, R., et al. Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain. JAMA 299(19), 2294-2303 (2008). doi : 10.1001/jama.299.19.2294.

8) Maitland, K. et al. Mortality after Fluid Bolus in African Children with Severe Infection. N. Engl. J. Med. 364(26), 2483-2495 (2011). doi : 10.1056/NEJMoa1101549.

9) Hilton, A. K. & Bellomo, R. A Critique of Fluid Bolus Resuscitation in Severe Sepsis. Crit. Care 16(1), 302 (2012). doi : 10.1186/cc11154.

10) Marik, P. E. Surviving Sepsis : Going Beyond the Guidelines. Ann. Intensive. Care 1(1), 17 (2011). doi : 10.1186/2110-5820-1-17.

酸に傾こうとする血液をアルカリに

P.79 掲載の参考文献

1) Rennke, H. G. & Denker, B. M. Renal Pathophysiology : The Essentials, 2nd edn. Lippincott Williams & Wilkins (2007).

P.105 掲載の参考文献

1) Hodgkin, J. E., Soeprono, F. F. & Chan, D. M. Incidence of Metabolic Alkalemia in Hospitalized Patients. Crit. Care Med. 8 (12), 725-728 (1980).

2) Rang, L. C. F., Murray, H. E., Wells, G. A. & Macgougan, C. K. Can Peripheral Venous Blood gases Replace Arterial Blood Gases in Emergency Department Patients? CJEM 4(1), 7-15 (2002).

3) Sterns, R. H. & Emmett, M. M. NephSAP Fluid, Electrolyte, and Acid-base Disturbances. 12 (3), 153-277 (2013).

P.119 掲載の参考文献

1) Hodgkin, J. E., Soeprono, F. F. & Chan, D. M. Incidence of Metabolic Alkalemia in Hospitalized Patients. Crit. Care. Med. 8(12), 725-728 (1980).

2) Anderson, L. E. & Henrich, W. L. Alkalemia-associated Morbidity and Mortality in Medical and Surgical Patients. South Med. J. 80(6), 729-733 (1987).

3) Patel, A. M. & Goldfarb, S. Got Calcium? Welcome to the Calcium-Alkali Syndrome. J. Am. Soc. Nephrol. 21(9), 1440-1443 (2010).

4) Luke, R. G. & Galla, J. H. It Is Chloride Depletion Alkalosis, Not Contraction Alkalosis. J. Am. Soc. Nephrol. 23(2), 204-207 (2012).

P.140 掲載の参考文献

1) Kraut, J. A. & Madias, N. E. Metabolic Acidosis : Pathophysiology, Diagnosis and Management. Nat. Rev. Nephrol. 6(5), 274-285 (2010). doi : 10.1038/nrneph.2010.33

2) Kraut, J. A. & Madias, N. E. Metabolic Acidosis : Pathophysiology, Diagnosis and Management. Nat. Rev. Nephrol. 6(5), 480-484 (2010).

3) Mehta, A. N., Emmett, J. B. & Emmett, M. Gold Mark : An Anion Gap Mnemonic for the 21st Century. Lancet 372(9642), 892 (2008).

身近な検査項目を深く捉える

P.164 掲載の参考文献

1) Renneboog, B., Musch, W., Vandemergel, X., Manto, M. U. & Decaux, G. Mild Chronic Hyponatremia Is Associated with Falls, Unsteadiness, and Attention Deficits. Am. J. Med. 119(1), 71.e1-71.e8, (2006). doi : 10.1016/j.amjmed.2005.09.026.

2) Leung, A. A., McAlister, F. A., Rogers, S. O., Pazo, V., Wright, A. & Bates, D. W. Preoperative Hyponatremia and Perioperative Complications. Arch. Intern. Med. 172(19), 1474 (2012). doi : 10.1001/archinternmed.2012.3992.

3) MD, J. G. V., et al. Diagnosis, Evaluation, and Treatment of Hyponatremia : Expert Panel Recommendations. Am. J. Med. 126, S1-S42 (2013).

4) Ellison, D. H. & Berl, T. Clinical Practice. The Syndrome of Inappropriate Antidiuresis. N. Engl. J. Med. 356(20), 2064-2072 (2007). doi : 10.1056/NEJMcp066837.

5) Sterns, R. H., Hix, J. K. & Silver, S. Treating Profound Hyponatremia : A Strategy for Controlled Correction. Am. J. Kidney Dis. 56(4), 774-779 (2010). doi : 10.1053/j.ajkd.2010.04.020.

6) Moritz, M. L. & Ayus, J. C. 100 cc 3% Sodium Chloride Bolus : A Novel Treatment for Hyponatremic Encephalopathy. Metab. Brain Dis. 25(1), 91-96(2010). doi : 10.1007/s11011-010-9173-2.

7) Adrogue, H. J. & Madias, N. E. Hyponatremia. N. Engl. J. Med. 342(21), 1581-1589(2000). doi : 10.1056/NEJM200005253422107.

8) 内田俊也日覧会誌 44 (1), 18-28 (2002).

9) Robertson, G. L., Aycinena P. & Zerbe, R. L. Neurogenic Disorders of Osmoregulation. Am. J. Med. 72(2), 339-353 (1982).

10) Adrogue, H. J. & Madias, N. E. Hypernatremia. N. Engl. J. Med. 342(20), 1493-1499 (2000). doi : 10.1056/NEJM200005183422006.

P.188 掲載の参考文献

1) Gennari, F. J., Hypokalemia. N. Engl. J. Med. 339(7), 451-458 (1998).

2) Giebisch, G., Krapf, R. & Wagner, C. Renal and Extrarenal Regulation of Potassium. Kidney International, (2007) p.14.

3) Palmer, B. F. A Physiologic-based Approach to the Evaluation of a Patient with Hypokalemia. Am. J. Kidney Dis. 56(6), 1184-1190 (2010).

4) McKean, S., Bennett, A. & Halasyamani, L. Hospital Medicine : Just The Facts. McGraw-Hill Professional (2008).

5) Antman, E. M., et al. ACC/AHA Guidelines for the Management of Patients with STelevation Myocardial Infarction--executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J. Am. Coll. Cardio. 43 (5), 671-719 (2004).

6) Cohn, J. N., Kowey, P. R., Whelton, P. K. & Prisant, L. M. New Guidelines for Potassium Replacement in Clinical Practice : A Contemporary Review by the National Council on Potassium in Clinical Practice. Arch. Int. Med. 160 (16), 2429-2436 (2000).

7) Goyal, A., et al. Serum Potassium Levels and Mortality in Acute Myocardial Infarction. JAMA 307(2), 157-164 (2012).

8) Greenfeld, D., Mickley, D., Quinlan, D. M. & Roloff, P. Hypokalemia in Outpatients with Eating Disorders. Am. J. Psychiatry 152(1), 60-63 (1995).

9) Ethier, J. H., Kamel, K. S., Magner, P. O., Lemann, J. & Halperin, M. L. The Transtubular Potassium Concentration in Patients with Hypokalemia and Hyperkalemia. Am. J. Kidney Dis. 15(4), 309-315 (1990).

10) Uptodate : http://www.uptodate.com/contents/causes-and-evaluation-of-hyperkalemiain-adults.

11) Kamel, K. S. & Halperin, M. L. Intrarenal Urea Recycling Leads to a Higher Rate of Renal Excretion of Potassium : An Hypothesis with Clinical Implications. Curr. Opin. Nephrol. Hy. 20(5), 547-554 (2011).

12) Sterns, R. H., Cox, M., Feig, P. U. & Singer, I. Internal Potassium Balance and the Control of the Plasma Potassium Concentration. Medicine (Baltimore). 60(5), 339-354 (1981).

13) Crop, M. J., Hoorn, E. J., Lindemans, J. & Zietse, R. Hypokalaemia and Subsequent Hyperkalaemia in Hospitalized Patients. Nephrol. Dial. Transplant. 22 (12), 3471-3477 (2007). doi : 10.1093/ndt/gfm471.

14) Whang, R. Magnesium Depletion As a Cause of Refractory Potassium Repletion. Arch. Intern. Med. 145 (9), 1686 (1985). doi : 10.1001/archinte.1985.00360090162024.

15) Imdad Ahmed SSC. Fatal Dysrhythmia Following Potassium Replacement for Hypokalemic Periodic Paralysis. West. J. Emerg. Med. 11(1), 57 (2010).

16) Montague, B. T., Ouellette, J. R. & Buller, G. K. Retrospective Review of the Frequency of ECG Changes in Hyperkalemia. Clin. J. Am. Soc. Nephrol. 3(2), 324-330 (2008).

17) Green, D., Green, H. D., New, D. I. & Kalra, P. A. The Clinical Significance of Hyperkalaemia-associated Repolarization Abnormalities in End-stage Renal Disease. Nephrol. Dial. Transplant. 28(1), 99-105 (2013).

18) Poggio, R., Grancelli, H. O. & Miriuka, S. G. Understanding the Risk of Hyperkalaemia in Heart Failure : Role of Aldosterone Antagonism. Postgrad. Med. J. 86(1013), 136-142 (2010).

19) Allon, M. Hyperkalemia in End-stage Renal Disease : Mechanisms and Management. J. Am. Soc. Nephrol. 6(4), 1134-1142 (1995).

20) Schaefer, T. J. & Wolford, R. W. Disorders of Potassium. Emerg. Med. Clin. North. Am. 23(3), 723-747-viii-ix (2005).

21) Palmer, B. F. A Physiologic-based Approach to the Evaluation of a Patient with Hyperkalemia. Am. J. Kidney Dis. 56(2), 387-393 (2010).

22) Shingarev, R. & Allon, M. A Physiologic-based Approach to the Treatment of Acute Hyperkalemia. Am. J. Kidney Dis. 56(3), 578-584 (2010).

最後に慢性期の腎臓管理を押える

P.210 掲載の参考文献

1) 日本腎臓学会編. CKD診療ガイド 2012. 1-160 (2012).

2) Levey, A. S., et al. The Definition, Classification, and Prognosis of Chronic Kidney Disease : A KDIGO Controversies Conference Report. 17-28 (2011).

3) Ishani, A., et al. Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-year Incidence of End-stage Renal Disease in the Multiple Risk Factor Intervention Trial. J. Am. Soc. Nephrol. 17(5), 1444-1452 (2006).

4) Imai, E., et al. Prevalence of Chronic Kidney Disease (CKD) in the Japanese General Population Predicted by the MDRD Equation Modified by a Japanese Coefficient. Clin. Exp. Nephrol. 11(2), 156-163 (2007).

5) Imai, E., et al. Slower Decline of Glomerular Filtration Rate in the Japanese General Population : A Longitudinal 10-year Follow-up Study. Hypertens. Res. 31(3), 433-441 (2008).

6) Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B. & Smith, D. H. Longitudinal Follow-up and Outcomes Among a Population with Chronic Kidney Disease in a Large Managed Care Organization. Arch. Intern. Med. 164(6), 659-663 (2004).

7) Ninomiya, T., et al. Chronic Kidney Disease and Cardiovascular Disease in a General Japanese Population : The Hisayama Study. Kidney Int. 68(1), 228-236 (2005).

8) Kovesdy, C. P. Significance of Hypo- and Hypernatremia in Chronic Kidney Disease. Nephrol. Dial. Transplant. 27(3), 891-898 (2012).

9) Einhorn, L.M. Arch. Intern. Med. 169(12), 1156-1162 (2009).

10) Bakris, G. L., et al. Preserving Renal Function in Adults with Hypertension and Diabetes : A Consensus Approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. 646-661 (2000).

11) Upadhyay, A., Earley, A., Haynes, S. M. & Uhlig, K. Systematic Review : Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier. Ann. Intern. Med. 154(8), 541-548 (2011).

12) Ruggenenti, P. & Remuzzi, G. Is the ONTARGET Renal Substudyactually off Target? Nat. Rev. Nephrol. 5(8), 436-437 (2009).

13) Iseki, K., Ikemiya, Y., Iseki, C. & Takishita, S. Proteinuria and the Risk of Developing End-stage Renal Disease. Kidney Int. 63(4), 1468-1474 (2003).

14) Fried, L. F., et al. Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy. N. Engl. J. Med. 369(20), 1892-1903 (2013).

15) Parving, H. H., et al. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes. N. Engl. J. Med. 345(12), 870-878 (2001).

16) Silverberg, D., Wexler, D., Blum, M., Wollman, Y. & Iaina, A. The Cardio-renal Anaemia Syndrome : Does it Exist? Nephrol. Dial. Transplant. 18(8), viii7-12 (2003).

17) Kovesdy, C. P., Anderson, J. E. & Kalantar-Zadeh, K. Association of Serum Bicarbonate Levels with Mortality in Patients with Non-dialysis-dependent CKD. Nephrol. Dial. Transplant. 24(4), 1232-1237 (2009).

18) de Brito-Ashurst, I., Varagunam, M., Raftery, M. J. & Yaqoob, M. M. Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status. J. Am. Soc. Nephrol. 20(9), 2075-2084 (2009).

19) Mahajan, A., Simoni, J., Sheather, S. J., Broglio, K. R., Rajab, M. H. & Wesson, D. E. Daily Oral Sodium Bicarbonate Preserves Glomerular Filtration Rate by Slowing its Decline in Early Hypertensive Nephropathy. Kidney Int. 78(3), 303-309 (2010).

20) Husted, F. C. & Nolph, K. D. NaHCO3 and NaCl Tolerance in Chronic Renal Failure II. Clin. Nephrol. 7(1), 21-25 (1977).

21) Kusaba, T., et al. Sodium Restriction Improves the Gustatory Threshold for Salty Taste in Patients with Chronic Kidney Disease. Kidney Int. 76(6), 638-643 (2009).

22) Levey, A. S., et al. Effect of Dietary Protein Restriction on the Progression of Kidney Disease : Long-term Follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am. J. Kidney Dis. 48(6), 879-888 (2006).

23) Brunori, G., et al. Efficacy and Safety of a Very-low-protein Diet When Postponing Dialysis in the Elderly : A Prospective Randomized Multicenter Controlled Study. Am. J. Kidney Dis. 49(5), 569-580 (2007).

24) Kalantar-Zadeh, K., et al. Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease. Clin. J. Am. Soc. Nephrol. 5(3), 519-530 (2010).

25) Goicoechea, M., et al. Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk. Clin. J. Am. Soc. Nephrol. 5(8), 1388-1393 (2010).

26) Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K. & Takishita, S. Significance of Hyperuricemia as a Risk Factor for Developing ESRD in a Screened Cohort. Am. J. Kidney Dis. 44(4), 642-650 (2004).

27) Hosoya, T., et al. The Effect of Febuxostat to Prevent a Further Reduction in Renal Function of Patients with Hyperuricemia Who Have Never Had Gout and are Complicated by Chronic Kidney Disease Stage 3 : Study Protocol for a Multicenter Randomized Controlled Study. Trials 15, 1-9 (2014).

P.228 掲載の参考文献

1) 日本移植学会臓器移植ファクトブック 2012.

2) 柴垣有吾, 東間紘, 寺岡慧腎移植における腎臓内科医・透析医の関与. 日腎会誌 46(1), 20-25 (2004).

3) SRTR & OPTN Annual Data Report, 2009 United States Organ Transplantation.

4) Kukla, A., et al. CKD Stage-to-stage Progression in Native and Transplant Kidney Disease. Nephrol. Dial. Transplant. 23(2), 693-700 (2008).

5) Djamali, A., Kendziorski, C., Brazy, P. C. & Becker, B. N. Disease Progression and Outcomes in Chronic Kidney Disease and Renal Transplantation. Kidney Int. 64(5), 1800-1807 (2003).

6) Lerma, E. V. & Rosner, M. H. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Springer (2013).

7) 日本移植学会・日本臨床腎移植学会腎移植臨床登録集計報告 (2012). 移植 47(6), 400-415 (2013).

8) Kido, R., et al. How do Living Kidney Donors Develop End-stage Renal Disease. Am. J. Transplant. 9(11), 2514-2519 (2009).

9) Ibrahim, H. N., et al. Long-term Consequences of Kidney Donation. N. Engl. J. Med. 360(5), 459-469 (2009).

10) Mandelbrot, D. A., Pavlakis, M., Karp, S. J., Johnson, S. R., Hanto, D. W. & Rodrigue, J. R. Practices and Barriers in Long-term Living Kidney Donor Follow-up : A Survey of U. S. Transplant Centers. Transplantation. 88(7), 855-860 (2009).

11) KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am. J. Transplant. 9(3), S1-155 (2009).

12) 仲谷達也ら腎臓移植の医療経済. 移植 44(1), 18-25 (2009).

13) Meier-Kriesche, H. -U. & Kaplan, B. Waiting Time on Dialysis as the Strongest Modifiable Risk Factor for Renal Transplant Outcomes : A Paired Donor Kidney Analysis. Transplantation. 74(10), 1377-1381 (2002).

14) 日本移植学会生体腎移植ガイドライン.

15) Bunnapradis, S. & Danovitch, G. M. Evaluation of Adult Kidney Transplant Candidates. Am. J. Kidney Dis. 50(5), 890-898 (2007).

16) Delmonico, F. Council of the Transplantation Society. A Report of the Amsterdam Forum on the Care of the Live Kidney Donor : Data and Medical Guidelines. 2005. pp. S53-66.

17) Segev, D. L., et al. Perioperative Mortality and Long-term Survival Following Live Kidney Donation. JAMA 303(10), 959-966 (2010).

書評

書評を投稿する

最近チェックした商品履歴

Loading...